ADA-SCID: symptoms, diagnosis and treatment
ADA-SCID is an inherited immune condition. Newborn screening can identify babies who need urgent specialist assessment before serious infections occur.
Sources checkedHow common is it in Ireland?
Birth incidence from the first two and a half years of ADA-SCID screening. The small number of cases makes the estimate uncertain.
HSE National Healthy Childhood Programme Screening Programmes Report 2024 (Table 1)Symptoms and signs
A baby can seem well at birth. Untreated babies may develop repeated or severe infections, persistent diarrhoea, oral thrush or poor weight gain in the first months of life.
What happens in the body
Without enough adenosine deaminase, substances that damage developing immune cells build up. This weakens several parts of the immune system and makes otherwise ordinary infections dangerous.
How it is diagnosed
A high-risk heel-prick result needs urgent specialist assessment and confirmatory blood tests. Clinicians may check different immune cells, enzyme activity and the responsible gene.
Treatment and follow-up
An immunology team can advise on infection precautions and decide which treatment is appropriate. Options can include enzyme replacement, a stem-cell transplant or gene therapy, depending on the case and access.
Complications and outlook
Serious infections can affect the lungs or other organs. Early detection and specialist treatment improve the outlook. Discuss vaccines, feeding and contact with sick people directly with the baby's team.
When to get help
If the screening team contacts you, follow its instructions immediately even if your baby seems well. For fever or signs of infection in a baby with suspected or confirmed ADA-SCID, use the emergency plan given by the team.
Sources and further reading
Use this guide for general information. A clinician can advise on your individual symptoms and care.